// App-Quantinova.ai

2730 : L-Asparaginase Monotherapy in Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma, Nasal Type: Results of A Phase II Study.

Researchers

Presenter

  • Xuejun Ma

Principal Investigators

  • Zuguang Xia

  • Kai Xue

  • Qunling Zhang

  • Xiaonan Hong

Medical Centers

  • Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

  • Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Acute lymphoblastic leukemia

  • T-cell lymphoma

  • Neutropenia

  • Lymphomas

  • Anemia

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

  • Gamma glutamyltransferase

Drug/Treatment

  • Alkaline phosphatase

  • Asparaginase

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim